KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on May 12, 2025 >>  ABB India 5586.2  [ 2.62% ]  ACC 1859.1  [ 2.53% ]  Ambuja Cements 541.45  [ 2.57% ]  Asian Paints Ltd. 2354.1  [ 2.34% ]  Axis Bank Ltd. 1204.1  [ 4.40% ]  Bajaj Auto 8038.9  [ 4.63% ]  Bank of Baroda 226.85  [ 3.04% ]  Bharti Airtel 1872.2  [ 1.30% ]  Bharat Heavy Ele 232.95  [ 7.47% ]  Bharat Petroleum 308.9  [ 0.72% ]  Britannia Ind. 5608.7  [ 3.39% ]  Cipla 1512  [ 2.27% ]  Coal India 395.45  [ 3.35% ]  Colgate Palm. 2610.75  [ 2.34% ]  Dabur India 475.3  [ 2.69% ]  DLF Ltd. 680.75  [ 7.80% ]  Dr. Reddy's Labs 1195.35  [ 3.37% ]  GAIL (India) 187.8  [ 3.36% ]  Grasim Inds. 2739.4  [ 4.02% ]  HCL Technologies 1669.65  [ 6.35% ]  HDFC Bank 1957.55  [ 3.62% ]  Hero MotoCorp 3990.55  [ 3.54% ]  Hindustan Unilever L 2382.95  [ 2.10% ]  Hindalco Indus. 651.85  [ 3.91% ]  ICICI Bank 1449.7  [ 4.39% ]  Indian Hotels Co 769.35  [ 6.94% ]  IndusInd Bank 788.65  [ -3.57% ]  Infosys L 1626.7  [ 7.91% ]  ITC Ltd. 435.5  [ 2.83% ]  Jindal St & Pwr 904.85  [ 5.73% ]  Kotak Mahindra Bank 2146.05  [ 2.01% ]  L&T 3586.6  [ 4.09% ]  Lupin Ltd. 2040.95  [ 0.15% ]  Mahi. & Mahi 3104.5  [ 4.08% ]  Maruti Suzuki India 12615.4  [ 2.96% ]  MTNL 41.4  [ 5.69% ]  Nestle India 2382.45  [ 2.52% ]  NIIT Ltd. 136.5  [ 5.65% ]  NMDC Ltd. 68.04  [ 5.72% ]  NTPC 348.7  [ 4.21% ]  ONGC 244  [ 3.94% ]  Punj. NationlBak 95.8  [ 4.19% ]  Power Grid Corpo 309.05  [ 3.17% ]  Reliance Inds. 1436.55  [ 4.27% ]  SBI 801.6  [ 2.85% ]  Vedanta 435.9  [ 6.88% ]  Shipping Corpn. 173.3  [ 6.98% ]  Sun Pharma. 1686.25  [ -3.36% ]  Tata Chemicals 848.25  [ 3.77% ]  Tata Consumer Produc 1144.9  [ 2.79% ]  Tata Motors 720.55  [ 1.70% ]  Tata Steel 151.55  [ 6.16% ]  Tata Power Co. 391.65  [ 5.52% ]  Tata Consultancy 3620.3  [ 5.17% ]  Tech Mahindra 1572.65  [ 5.34% ]  UltraTech Cement 11738.55  [ 3.21% ]  United Spirits 1563.8  [ 2.06% ]  Wipro 257.4  [ 6.41% ]  Zee Entertainment En 117.15  [ 1.12% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

TEJNAKSH HEALTHCARE LTD.

12 May 2025 | 12:00

Industry >> Hospitals & Medical Services

Select Another Company

ISIN No INE030T01027 BSE Code / NSE Code 539428 / TEJNAKSH Book Value (Rs.) 12.20 Face Value 5.00
Bookclosure 28/09/2024 52Week High 31 EPS 0.87 P/E 24.94
Market Cap. 44.28 Cr. 52Week Low 21 P/BV / Div Yield (%) 1.79 / 0.00 Market Lot 1.00
Security Type Other

NOTES TO ACCOUNTS

You can view the entire text of Notes to accounts of the company for the latest year
Year End :2024-03 

(i) Certain assets included under Property, plant and equipment are held as pledge against loans taken by the Company, (refer note no. 17)

(ii) Rs. 804.84 lacs has been capitalised and transferred to buildings, plant and equipments, furniture and fixtures during the year ended March 31, 2023.

(iii) Lease contracts entered by the Company pertains for the office taken on lease to conduct its business in the ordinary course.

(iv) The Uran hospital building was acquired in 2021 for a total of Rs. 7.14 crores through an e-auction facilitated by the Bank of Baroda under the provisions of the SARFAESI Act, 2002. Subsequently, the borrower, whose property was auctioned, initiated legal proceedings at the Debt Recovery Tribunal III in Mumbai. The borrower alleges deficiencies in the auction process, with Bank of Baroda being the primary defendant, and the company being included in the case as a concerned party.

(i) Impairment testing of goodwill

The goodwill is measured as the excess of the sum of the consideration transferred over the net of acquisition date amount of identified assets aquired and liabilities assumed.

For the purpose of impairment testing, goodwill is allocated to the cash generating units (businesses acquired) that is expected to benefit from the synergies of the combination.

The Company tests whether goodwill has suffered any impairment periodically. The recoverable amount of a cash generating unit (CGU) is determined based on fair value less cost to sell of the underlying asset.

If the recoverable amount of an asset (or CGU) is estimated to be less than its carrying amount, the carrying amount of the asset (or CGU) is reduced to its recoverable amount. An impairment loss is recognised in the statement of profit and loss.

Based on the evaluation by the management, the goodwill has not suffered any impairment during the year.

Bank deposits earns interest at fixed rates. Short term deposits are generally made for varying periods between seven days to twelve months, depending on the cash requirements of the Company, and earn interest at the respective deposit rates

The Company offsets tax assets and liabilities if and only if it has a legally enforceable right to set off current tax assets and current tax liabilities and the deferred tax assets and deferred tax liablities relate to income taxes levied by the same tax authority

* The company has subdivided equity shares, each with a face value of Rs. 10/-, into equity shares with a face value of Rs. 5/- each, fully paid up, as approved by the shareholders at an extraordinary general meeting held on 24th June 2023, with the record date set as 19th July 2023.

Terms/rights attached to equity shares

The company has only one class of equity shares having par value of INR 5 per share. Each holder of equity shares is entitled to one vote per share. The company declares and pays dividends in Indian rupees. The dividend proposed by the Board of Directors is subject to the approval of the shareholders in the ensuing Annual General Meeting.

In the event of liquidation of the company, the holders of equity shares will be entitled to receive remaining assets of the company, after distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.

Details Of Dues To Micro And Small Enterprises As Defined Under Micro, Small And Medium Enterprises Development Act, 2006 (MSMED Act, 2006)

The Ministry of Micro, Small and Medium Enterprises has issued an office memorandum dated 26 August 2008 which recommends that the Micro and Small Enterprises should mention in their correspondence with its customers the Entrepreneurs Memorandum Number as allocated after filing of the Memorandum. Accordingly, the disclosure in respect of the amounts payable to such enterprises as at March 31, 2024 has been made in the financial statements based on information received and available with the Company. Further in view of the management, the impact of interest, if any, that may be payable in accordance with the provisions of the Micro, Small and Medium Enterprises Development Act,2006 ('The MSMED Act') is not expected to be material. The Company has not received any claim for interest from any supplier.

The weighted average number of shares takes into account the weighted average effect of changes in share transactions during the year. There have been no other transactions involving Equity shares or potential Equity shares between the reporting date and the date of authorisation of these financial statements.

The basic and diluted EPS for the prior year have been restated considering the face value of 5/- each in accordance with Ind AS 33 - "Earnings per Share" on account of sub-division of the Ordinary (equity) Shares of face value 10/- each into Ordinary (equity) Shares of face value of 5/- each.

100/152

Gratuity

The Company has a defined benefit gratuity plan, where under employee who has completed five years or more of service gets a gratuity on departure at 15 days salary (last drawn basic salary) for each completed year of service subject. Vesting occurs upon completion of 5 years of service. The Gratuity is unfunded.

The following table summarizes the components of net benefit expenses recognised in the Statement of Profit and Loss and the amounts recognized in the Balance Sheet.

(vii) Terms and conditions of transactions with related parties

The sales to and purchases from related parties are made on terms equivalent to those that prevail in arm's length transactions, Outstanding balances at the year end are unsecured and interest free and settlement occurs in cash. For the year ended March 31, 2024, the company has not recorded any impairment of receivables relating to amount owed by related parties (March 31, 2023: NIL). This assessment is undertaken each financial year through examining the financial position of the related party and market in which the related party operates,

The Company has a single operating segment, namely, health care services and the information reported to the chief operating decision maker (CODM) for the purposes of resource allocation and assessment of performance focusses on this operating segment. Further the company does not have any separate geographic segment other than India. Accordingly, the amounts appearing in these financial statements relate to this operating segment.

The management assessed that the fair value of cash and cash equivalent, trade receivables, trade payables, and other current financial assets and liabilities approximate their carrying amounts largely due to the short term maturities of these instruments.

The fair values for security deposits were calculated based on cash flows discounted using a current lending rate. They are classified as level 3 fair values in the Fair value hierarchy due to the inclusion of unobservable inputs including counterparty credit risk.

The fair values of non current borrowings are based on discounted cash flows using a current borrowing rate. They are classified as level 3 fair values in the fair value hierarchy due to the use of unobservable inputs, including own credit risk.

The Company manages financial risk relating to the operations through internal risk reports which analyse exposure by degree and magnitude of risk.These risks include market risk (including interest rate risk and other price risk), credit risk and liquidity risk. The focus of the chief operating decision maker (CODM) is to assess the unpredictability of the financial environment and to mitigate potential adverse effects, if any, on the financial performance of the Company.

The Company does not enter into or trade financial instruments including derivative financial instruments for speculative purpose.

(A) Credit risk

Credit risk is the risk that counterparty will default on its contractual obligation resulting in a financial loss to the company. The credit risk arises primarily on trade receivables and deposits with banks and other financial instruments.

The Company's hospital and healthcare services and sale of medical goods are on the counter sale i.e. on cash basis and as such no credit risk arises.

Exposures to customers outstanding at the end of each reporting period are reviewed by the Company to determine expected credit losses. Historical trends of impairment of trade receivables do not reflect any credit losses. Given that there is no substantial change in the economic environment affecting customers of the Company, the Company expects the historical trend of immaterial credit losses to continue.

Credit risk on cash and bank balances is limited as company counterparties are banks with high credit ratings assigned credit rating agencies.

(B) Liquidity risk

Liquidity risk refers to the risk that the Company cannot meet its financial obligations. The objective of liquidity risk management is to maintain sufficient liquidity and ensure that funds are available for use as per requirements. The Company consistently generated sufficient cash flows from operations to meet its financial obligations as and when they fall due.

The following tables detail the Company's remaining contractual maturity for its financial liabilities with agreed repayment periods. The tables have been drawn up based on the undiscounted cash flows of financial liabilities based. It include both interest and principal cash flows. The contractual maturity is based on the earliest date on which the Company may be required to pay.

(C) Market risk

Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in the market prices. The Company is exposed in the ordinary course of its business to risks related to changes in foreign currency exchange rates. The Company's exposure to foreign currency risk and other price risk is not significant.

Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in the market interest rates. The Company's exposure to the risk of changes in the market interest rates relates primarily to the Company's debt obligations with floating interest rates.

However, the company does not expect any material change in the interest rates in the foreseable future and therefore does not expects any significantly risk on account of change in interest rate as at the respective reporting dates.

Interest rate sensitivity

The following table demonstrates the sensitivity to a reasonably possible change in interest rates on that portion of loans and borrowings taken at floating rates. With all other variables held constant, the Company's profit/ (loss) before tax is affected through the impact on floating rate borrowings, as follows:

For the purpsoe of the company's capital management, capital includes issued equity capital, equity instruments, share premium and all other equity reserves attributable to the equity holders. The primary objective of the Company's capital management is to maximise the shareholder value.

The Company manages its capital so as to safeguard its ability to continue as going concerns through the optimization of the debt and equity balance. The capital structure of the Company consists of net debt (i.e. borrowings offset by cash and bank balances) and equity of the Company (comprising issued capital, reserves and retained earnings). The Company monitors capital using a ratio of'net debt' to equity. The Company's net debt to equity ratio is as follows.

139. Relationship with Struck off Companies I

The Company doesn't have transaction with the Companies Struck off under Section 248 of the Companies Act, 2013 or Section 560 of the Companies Act, 1956 during the financial year.

42. No transaction to report against the following disclosure requirements as notified by MCA pursuant to amended Schedule III:

(a) Crypto currency or virtual currency

(b) Benami property held under prohibition of Benami Property transaction Act, 1988 and rules made thereunder

(c) Relating to borrowed funds:

i) wilful defaulter

ii) Utilisation of borrowed funds & share premium

iii) Borrowings obtained on the basis of security of current assets

iv) Discrepancy in utilisation of borrowings

v) Current maturity of long term borrowings.

43. No funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other person(s) or entity(ies), including foreign entities ("Intermediaries") with the understanding, whether recorded in writing or otherwise, that the Intermediary shall lend or invest in party identified by or on behalf of the Company (Ultimate Beneficiaries) other than in the ordinary course of business with its subsidiary companies. The Company has not received any fund from any party(s) (Funding Party) with the understanding that the Company shall whether, directly or indirectly lend or invest in other persons or entities identified by or on behalf of the Company ("Ultimate Beneficiaries") or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

44. The financial statements for the year ended 31st March, 2024 were approved for issue by the Board of Directors on 28th May, 2024.

45. The company has reviewed and there are no long-term contracts for which there are any material foreseeable losses. The company has ensured that adequate provisions as required under any law/ accounting standards for material foreseeable losses on derivative contracts has been made in the books of accounts.

46. The figures for the previous year have been restated/regrouped wherever necessary to make them comparable.